The United States has pulled the plug on its HIV funding programme in South Africa, a decision that threatens to unravel years of progress against the epidemic. But the United Kingdom has stepped into the breach, pledging emergency support to protect the most vulnerable communities. For the millions of South Africans reliant on antiretroviral drugs and prevention services, the shift is a matter of life and death.
The US President's Emergency Plan for AIDS Relief (PEPFAR) has been a cornerstone of the global fight against HIV since 2003, injecting billions into prevention, treatment and care. South Africa, bearing the world's largest HIV burden with some 7.8 million people living with the virus, has been the single biggest recipient. But the Trump administration's decision to axe funding, announced late last week, has sent shockwaves through clinics and community groups across the country.
Activists say the cuts will mean thousands of patients losing access to lifesaving medication. 'This is a catastrophe,' said Thembi Nkosi, a nurse at a public clinic in Soweto. 'Our patients rely on these drugs. Without them, they will die.' The US decision, part of a broader withdrawal from global health commitments, has been condemned by health experts as short-sighted and cruel.
But Britain has moved quickly. The Foreign, Commonwealth and Development Office (FCDO) confirmed a £200 million emergency package to cover the gap, focusing on community-based care for pregnant women, children and key populations at highest risk. 'We cannot allow lives to be lost because of political choices,' said a spokesperson. 'The UK stands with South Africa in this fight.'
The money will be channelled through the Global Fund and local organisations. It is a stopgap, not a permanent solution. But campaigners hope it will prevent the immediate collapse of services. 'This is a lifeline,' said Bheki Mthembu, director of the Treatment Action Campaign. 'But we need a long-term commitment. The US has left a gaping hole.'
The economic impact is stark. South Africa's fragile health system, already buckling under unemployment and inequality, cannot absorb the loss without UK support. For the ordinary worker, the stakes are deeply personal. Agyness Dlamini, 34, a factory worker in Johannesburg, has been on antiretroviral therapy for five years. 'If the drugs stop, I stop,' she said. 'I have two children. I can't afford to be sick.'
The UK's move is rare: a dramatic intervention by one donor to patch the retreat of another. But it underscores the volatility of relying on foreign aid. For unions and community groups, the crisis highlights the need for South Africa to build its own capacity. 'We cannot be at the mercy of foreign budgets,' said Zwelinzima Vavi, general secretary of the South African Federation of Trade Unions. 'Our people deserve stable, universal healthcare.'
The immediate crisis may be averted, but the long road ahead remains uncertain. The UK has bought time, but the question of who pays for HIV treatment in South Africa next year is still unanswered.